Regeneron Pharmaceuticals Inc. buy Truist Financial Co.
Start price
26.03.24
/
50%
€892.50
Target price
26.03.25
€1,046.4
Performance (%)
-7.54%
Price
26.04.24
€825.20
Summary
This prediction is currently active. With a performance of -7.54%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 26.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.902% | -1.902% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $1,135.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€885.20
03.04.24
03.04.24
€1,049.8
03.04.25
03.04.25
-6.78%
26.04.24
26.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
18.12.23
18.12.23
€957.22
18.12.24
18.12.24
5.93%
26.04.24
26.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€729.00
28.11.23
28.11.23
€951.37
28.11.24
28.11.24
13.20%
26.04.24
26.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€734.00
16.08.23
16.08.23
€959.41
16.08.24
16.08.24
12.43%
26.04.24
26.04.24